Table 1. Clinical characteristics and metabolic parameters of nondiabetic and diabetic patients.
| Nondiabetic patients | Diabetic patients | P-value* | |
|---|---|---|---|
| n (male) | 12 | 12 | |
| Age (years) | 74.2 ± 8.9 | 70.4 ± 7.2 | 0.270 |
| Duration of diabetes (years) | - | 6.5 [2.3–17.5] | - |
| Body weight (kg) | 60.6 ± 9.3 | 63.7 ± 8.4 | 0.392 |
| BMI (kg/m2) | 23.5 ± 3.0 | 23.8 ± 3.1 | 0.772 |
| WC (cm) | 84.9 ± 6.7 | 84.6 ± 9.4 | 0.931 |
| SBP (mmHg) | 133.4 ± 17.3 | 127.3 ± 14.8 | 0.364 |
| DBP (mmHg) | 69.4 ± 13.1 | 71.2 ± 13.8 | 0.753 |
| FPG (mmol/L) | 5.5 ± 0.9 | 7.5 ± 1.4 | <0.001 |
| IRI (pmol/L) | 39.0 [20.3–51.5] | 43.5 [27.8–78.3] | 0.453 |
| HbA1c (%) | 5.6 ± 0.3 | 7.0 ± 0.6 | <0.001 |
| HOMA-IR | 1.9 ± 1.5 | 4.1 ± 4.5 | 0.131 |
| TC (mmol/L) | 4.4 ± 1.1 | 4.1 ± 1.0 | 0.481 |
| TG (mmol/L) | 1.4 [1.1–2.1] | 1.2 [0.8–1.4] | 0.073 |
| HDL-C (mmol/L) | 1.4 ± 0.4 | 1.2 ± 0.3 | 0.278 |
| LDL-C (mmol/L) | 2.5 ± 1.0 | 2.4 ± 0.7 | 0.779 |
| hsCRP (µg/mL) | 1.3 [0.2–4.4] | 2.3 [0.3–3.9] | 0.686 |
| Proportion of patients with/taking: | |||
| hypertension (%) | 83.3 | 100.0 | 0.478 |
| dyslipidemia (%) | 83.3 | 83.3 | >0.999 |
| calcium antagonist (%) | 66.7 | 33.3 | 0.220 |
| ACE/ARB (%) | 41.7 | 91.7 | 0.027 |
| statins (%) | 66.7 | 66.7 | >0.999 |
| antidiabetic medications (%) | 0.0 | 83.3 | - |
Data are shown as the mean ± SD or median [IQR]. BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; IRI, immunoreactive insulin; HbA1c, hemoglobin A1c; HOMA-IR, homeostasis model assessment of insulin resistance; TC, total cholesterol; TG, triglycerides; HDL-C, HDL-cholesterol; LDL-C, LDL-cholesterol; hsCRP, high-sensitive C-reactive protein; ACE, angiotensin-converting enzyme; and ARB, angiotensin II type 1 receptor blocker.
*
nondiabetic versus diabetic patients